Rydex Biotechnology
Historical Performance
Objective And Strategy
ObjectiveCapital appreciation.
StrategyIt invests in companies involved in the biotechnology area. Companies include research and development, genetic or other biological engineering, and the design, manufacture or sale of related biotechnology products or services. Aims to create a liquid Portfolio of stocks and to be fully invested at all times. Uses a quantitative approach, continuously monitoring the Portfolio. Stocks are added or deleted based on market capitalization, liquidity and correlation relative to the entire industry sector.
Tax Inefficient Fund
Asset classes that make large ordinary income distributions or generate significant short term capital gains are tax inefficient. Asset classes that match this description include REITs, commodities funds and absolute return funds.
Principle Risks
N/A
-
Sector Equity05/2001
-
Documents
-
Fund Family Summary Prospectus
Updated 05-01-2021
-
Fund Annual Report
Updated 12-31-2020
-
Fund Prospectus
Updated 05-01-2021
-
Fund SAI
Updated 05-01-2021
-
Fund Family Summary Prospectus